Immucell (ICCC) Inventory Average (2011 - 2026)
Immucell's (ICCC) quarterly Inventory Average came in at $9.5 million in Q4 2025, up 30.85% YoY from $7.3 million in Q4 2024, and up 5.38% on a QoQ basis from $9.0 million in Q3 2025.
Immucell (ICCC) Inventory Average (2011 - 2026) Analysis & Trends
Immucell (ICCC) has 15 years of Inventory Average data on file, last reported at $9.5 million in Q4 2025.
- Quarterly Inventory Average rose 30.85% year-over-year to $9.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.5 million (up 30.85% YoY) and the FY2025 annual result came in at $8.2 million, up 9.75% from the prior year.
- Inventory Average climbed to $9.5 million in Q4 2025, from $9.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $9.5 million in Q4 2025 to a low of $2.1 million in Q1 2021.
- A 5-year average of $5.9 million and a median of $7.1 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 97.26% — and 2024, when it slipped 4.11%.
- Tracing ICCC's Inventory Average over 5 years: stood at $2.9 million in 2021, then jumped by 97.26% to $5.7 million in 2022, then soared by 33.82% to $7.6 million in 2023, then fell by 4.11% to $7.3 million in 2024, then surged by 30.85% to $9.5 million in 2025.
- The last three Inventory Average figures came in at $9.5 million (Q4 2025), $9.0 million (Q3 2025), and $7.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 9.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.17 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Sep 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 7.22 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 7.60 Mn |
| Sep 30, 2023 | 7.46 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 6.18 Mn |
| Dec 31, 2022 | 5.68 Mn |
| Sep 30, 2022 | 4.96 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 3.26 Mn |
| Dec 31, 2021 | 2.88 Mn |
| Sep 30, 2021 | 2.54 Mn |
| Jun 30, 2021 | 2.27 Mn |